Chemoinformaics analysis of Bayachinine:Ldlo=>1
| Molecular Weight | 338.403 | nRot | 4 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 19 |
| Exact Molecular Weight | 338.152 | nRing | 3 |
| Solubility: LogS | -4.711 | nHRing | 1 |
| Solubility: LogP | 4.872 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 52.9474 |
| nHD | 1 | BPOL | 26.4106 |
| QED | 0.827 |
| Synth | 2.996 |
| Natural Product Likeliness | 1.75 |
| NR-PPAR-gamma | 0.469 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.004 |
| HIA | 0.005 |
| CACO-2 | -4.646 |
| MDCK | 0.0000145 |
| BBB | 0.065 |
| PPB | 0.975104 |
| VDSS | 0.7 |
| FU | 0.0319112 |
| CYP1A2-inh | 0.508 |
| CYP1A2-sub | 0.857 |
| CYP2c19-inh | 0.967 |
| CYP2c19-sub | 0.369 |
| CYP2c9-inh | 0.926 |
| CYP2c9-sub | 0.939 |
| CYP2d6-inh | 0.651 |
| CYP2d6-sub | 0.869 |
| CYP3a4-inh | 0.713 |
| CYP3a4-sub | 0.282 |
| CL | 15.191 |
| T12 | 0.242 |
| hERG | 0.035 |
| Ames | 0.546 |
| ROA | 0.22 |
| SkinSen | 0.189 |
| Carcinogencity | 0.433 |
| EI | 0.419 |
| Respiratory | 0.604 |
| NR-Aromatase | 0.553 |
| Antiviral | Yes |
| Prediction | 0.575213 |